Ocean Biomedical Inc. (OCEA)
0.13
-0.02 (-10.96%)
At close: Feb 20, 2025, 3:59 PM
0.14
0.22%
After-hours: Feb 20, 2025, 06:37 PM EST
undefined% (undefined)
| Bid | 0.13 |
| Market Cap | 4.70M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.95 |
| PE Ratio (ttm) | -0.14 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.14 |
| Volume | 23,547,422 |
| Avg. Volume (20D) | 29,568,723 |
| Open | 0.14 |
| Previous Close | 0.15 |
| Day's Range | 0.13 - 0.14 |
| 52-Week Range | 0.11 - 7.79 |
| Beta | undefined |
About OCEA
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatm...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 8, 2021
Employees 9
Stock Exchange NASDAQ
Ticker Symbol OCEA
Website http://www.oceanbiomedical.com
Analyst Forecast
According to 2 analyst ratings, the average rating for OCEA stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 50.00%
Hold 0.00%
Sell 0.00%
3 weeks ago
-26.33%
Ocean Biomedical shares are trading higher after t...
Unlock content with
Pro Subscription
